The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Protein Kinase G Transmits the Cardioprotective Signal From Cytosol to Mitochondria
Abstract
Ischemic and pharmacological preconditioning can be triggered by an intracellular signaling pathway in which G i -coupled surface receptors activate a cascade including phosphatidylinositol 3-kinase, endothelial nitric oxide synthase, guanylyl cyclase, and protein kinase G (PKG). Activated PKG opens mitochondrial K ATP channels (mitoK ATP ) which increase production of reactive oxygen species. Steps between PKG and mitoK ATP opening are unknown. We describe effects of adding purified PKG and cGMP on K + transport in isolated mitochondria. Light scattering and respiration measurements indicate PKG induces opening of mitoK ATP similar to K ATP channel openers like diazoxide and cromakalim in heart, liver, and brain mitochondria. This effect was blocked by mitoK ATP inhibitors 5-hydroxydecanoate, tetraphenylphosphonium, and glibenclamide, PKG-selective inhibitor KT5823, and protein kinase C (PKC) inhibitors chelerythrine, Ro318220, and PKC-ε peptide antagonist εV 1-2 . MitoK ATP are opened by the PKC activator 12-phorbol 13-myristate acetate. We conclude PKG is the terminal cytosolic component of the trigger pathway; it transmits the cardioprotective signal from cytosol to inner mitochondrial membrane by a pathway that includes PKC-ε.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“MitoSNO has been reported to be protective in mice with cardiomyocyte deficiency of protein kinase G18, indicating that the cardio-protection conferred by MitoSNO is not due to nonmitochondrial pathways that operate through cyclic GMP–protein kinase G signaling3,6”
From Cardioprotection by S-nitrosation of a cysteine switch on mitochondrial complex I (2013) · cites this paper as [6]
Citations
Cites
DETERMINATION OF SERUM PROTEINS BY MEANS OF THE BIURET REACTION
Gornall, A. G., Bardawill, C. J., & David, M. M. (1949) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)57021-6 · Cited by 16,164
Inhibition of protein kinase C μ by various inhibitors. Inhibition from protein kinase c isoenzymes
Gschwendt, M., Dieterich, S., Rennecke, J., Kittstein, W., Mueller, H.-J., & Johannes, F.-J. (1996) · FEBS Letters · doi:10.1016/0014-5793(96)00785-5 · Cited by 644
Opposing cardioprotective actions and parallel hypertrophic effects of δPKC and ɛPKC
Chen, L., Hahn, H. S., Wu, G., Chen, C., Liron, T., Schechtman, D., Cavallaro, G., Banci, L., Guo, Y., Bolli, R., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.191369098 · Cited by 537
Isoenzyme specificity of bisindolylmaleimides, selective inhibitors of protein kinase C
Wilkinson, S. E., Parker, P. J., & Nixon, J. (1993) · Biochemical Journal · doi:10.1042/bj2940335 · Cited by 522
Ping, P., Zhang, J., Qiu, Y., Tang, X., Manchikalapudi, S., Cao, X., & Bolli, R. (1997) · Circulation Research · doi:10.1161/01.res.81.3.404 · Cited by 482
The Mitochondrial K Channel as a Receptor for Potassium Channel Openers
Garlid, K., Pauček, P., Yarov-Yarovoy, V. M., Sun, X., & Schindler, P. A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.15.8796 · Cited by 445
Self-citationMitochondrial PKCε and MAPK Form Signaling Modules in the Murine Heart
Baines, C. P., Zhang, J., Wang, G.-W., Zheng, Y.-T., Xiu, J. X., Cardwell, E. M., Bolli, R., & Ping, P. (2002) · Circulation Research · doi:10.1161/01.res.0000012702.90501.8d · Cited by 429
Gray, M. O., Karliner, J. S., & Mochly‐Rosen, D. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.49.30945 · Cited by 388
A Protein Kinase C Translocation Inhibitor as an Isozyme-selective Antagonist of Cardiac Function
Johnson, J. A., Gray, M. O., Chen, C., & Mochly‐Rosen, D. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.40.24962 · Cited by 377
Modulation of Mitochondrial ATP-Dependent K+Channels by Protein Kinase C
Sato, T., O'Rourke, B. P., & Marbán, E. (1998) · Circulation Research · doi:10.1161/01.res.83.1.110 · Cited by 366
Cited by
Sorted by citations
Items 101–200 of 307
Using hydrogen sulfide to design and develop drugs
Calderone, V., Martelli, A., Testai, L., Citi, V., & Breschi, M. C. (2015) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2016.1122590 · Cited by 65
Miao, Q., Wang, S., Miao, S., Wang, J., Xie, Y., & Yang, Q. (2011) · Phytomedicine · doi:10.1016/j.phymed.2011.06.023 · Cited by 65
Mitochondrial reactive oxygen species: which ROS signals cardioprotection?
Garlid, A. O., Jabůrek, M., Jacobs, J. P., & Garlid, K. (2013) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00858.2012 · Cited by 66
Self-citationContribution of Delayed Intracellular pH Recovery to Ischemic Postconditioning Protection
Inserte, J., Ruiz‐Meana, M., Rodríguez‐Sinovas, A., Barba, I., & García‐Dorado, D. (2010) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3312 · Cited by 64
Guo, D., Nguyen, T. T. M., Ogbi, M., Tawfik, H. E., Ma, G., Yu, Q., Caldwell, R. W., & Johnson, J. A. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01306.2006 · Cited by 63
Methner, C., Lukowski, R., Grube, K., Loga, F., Smith, R. A. J., Murphy, M. P., Hofmann, F., & Krieg, T. (2013) · Basic Research in Cardiology · doi:10.1007/s00395-013-0337-1 · Cited by 62
D’Ascenzo, F., Femminò, S., Ravera, F., Angelini, F., Caccioppo, A., Franchin, L., Grosso, A., Comità, S., Cavallari, C., Penna, C. R. R., et al. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105715 · Cited by 61
Redox Control of Cardiac Excitability
Aggarwal, N. T., & Makielski, J. C. (2012) · Antioxidants and Redox Signaling · doi:10.1089/ars.2011.4234 · Cited by 62
cGMP-Dependent Protein Kinases (cGK)
Hofmann, F. B., & Wegener, J. W. (2013) · Methods in molecular biology · doi:10.1007/978-1-62703-459-3_2 · Cited by 61
Miki, T., Miura, T., Yano, T., Takahashi, A., Sakamoto, J., Tanno, M., Kobayashi, H., Ikeda, Y., Nishihara, M., Naitoh, K., et al. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.095745 · Cited by 60
Burelle, Y., Khairallah, M., Ascah, A., Allen, B. G., Deschepper, C. F., Petrof, B. J., & Rosiers, C. D. (2009) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2009.09.004 · Cited by 61
Nitrite as a mediator of ischemic preconditioning and cytoprotection
Murillo, D., Kamga, C., Mo, L., & Shiva, S. (2011) · Nitric Oxide · doi:10.1016/j.niox.2011.01.003 · Cited by 57
Myocardial protection against reperfusion injury: The cGMP pathway
Agulló, L., Sartório, C. L., Ruiz‐Meana, M., & David Garcia-dorado, A. (2009) · Thrombosis and Haemostasis · doi:10.1160/th08-11-0764 · Cited by 57
Dost, T., Cohen, M. V., & Downey, J. M. (2008) · Basic Research in Cardiology · doi:10.1007/s00395-008-0718-z · Cited by 57
Self-citationKuno, A., Solenkova, N. V., Solodushko, V., Dost, T., Liu, Y., Yang, X., Cohen, M. V., & Downey, J. M. (2008) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00209.2008 · Cited by 57
Self-citationInteractions between nitric oxide, oxygen, reactive oxygen species and reactive nitrogen species
Brown, G. C., & Borutaitė, V. (2006) · Biochemical Society Transactions · doi:10.1042/bst0340953 · Cited by 57
Silic‐Benussi, M., Cannizzaro, E., Venerando, A., Cavallari, I., Petronilli, V., Rocca, N. L., Marin, O., Chieco‐Bianchi, L., Lisa, F. D., D’Agostino, D. M., et al. (2009) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2009.02.001 · Cited by 55
Postconditioning leads to an increase in protein S-nitrosylation
Tong, G., Aponte, A. M., Kohr, M. J., Steenbergen, C., Murphy, E., & Sun, J. (2014) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00660.2013 · Cited by 55
Sivaraman, V., Hausenloy, D. J., Kolvekar, S. K., Hayward, M. P., Yap, J. A., Lawrence, D. R., Salvo, C. D., & Yellon, D. M. (2009) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2009.02.013 · Cited by 52
Weerateerangkul, P., Chattipakorn, S. C., & Chattipakorn, N. (2011) · Medical Science Monitor · doi:10.12659/msm.881385 · Cited by 53
Mitochondrial Permeability Transition in Cardiac Cell Injury and Death
Honda, H. M., & Ping, P. (2006) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-006-0642-0 · Cited by 55
Cardioprotective PKG-independent NO signaling at reperfusion
Cohen, M. V., Yang, X., Liu, Y., Solenkova, N. V., & Downey, J. M. (2010) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00527.2010 · Cited by 52
Self-citationBorutaitė, V., Morkūnienė, R., Arandarčikaitė, O., Jekabsone, A., Barauskaitė, J., & Brown, G. C. (2009) · Journal of Biomedical Science · doi:10.1186/1423-0127-16-70 · Cited by 51
Penna, C. R. R., Perrelli, M. G., Tullio, F., Angotti, C., Camporeale, A., Poli, V., & Pagliaro, P. (2013) · Basic Research in Cardiology · doi:10.1007/s00395-013-0371-z · Cited by 51
Cancherini, D. V., Queliconi, B. B., & Kowaltowski, A. J. (2007) · Cardiovascular Research · doi:10.1016/j.cardiores.2006.11.035 · Cited by 50
Chernyavsky, A. I., Shchepotin, I. B., & Grando, S. A. (2015) · International Immunopharmacology · doi:10.1016/j.intimp.2015.05.033 · Cited by 50
Molecular aspects of ischaemic postconditioning
Kaur, S., Jaggi, A. S., & Singh, N. (2009) · Fundamental and Clinical Pharmacology · doi:10.1111/j.1472-8206.2009.00733.x · Cited by 49
Therapeutic Implications for PDE2 and cGMP/cAMP Mediated Crosstalk in Cardiovascular Diseases
Sadek, M. S., Cachorro, E., Kämmerer, S., & El‐Armouche, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207462 · Cited by 49
Orphan targets for reperfusion injury
Inserte, J., Barrabés, J. A., Hernando, V., & David Garcia-dorado, A. (2009) · Cardiovascular Research · doi:10.1093/cvr/cvp109 · Cited by 49
Citi, V., Corvino, A., Fiorino, F., Frecentese, F., Magli, E., Perissutti, E., Santagada, V., Brogi, S., Flori, L., Gorica, E., et al. (2020) · Journal of Advanced Research · doi:10.1016/j.jare.2020.02.017 · Cited by 49
Kim, M., Kim, M. J., Yoon, I. S., Ahn, J., Lee, S. H., Baik, E. J., Moon, C., & Jung, Y. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706922 · Cited by 48
Mitochondrial Therapeutics for Cardioprotection
Carreira, R., Lee, P. P. W., & Gottlieb, R. A. (2011) · Current Pharmaceutical Design · doi:10.2174/138161211796904777 · Cited by 48
Shoup, T. M., Elmaleh, D. R., Brownell, A., Zhu, A., Guerrero, J., & Fischman, A. J. (2010) · Molecular Imaging and Biology · doi:10.1007/s11307-010-0349-2 · Cited by 47
Werbner, B., Tavakoli‐Rouzbehani, O. M., Fatahian, A. N., & Boudina, S. (2023) · The Journal of Cardiovascular Aging · doi:10.20517/jca.2022.42 · Cited by 44
Puerta, E., Hervías, I., Goñi‐Allo, B., Lasheras, B., Jordán, J., & Aguirre, N. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05825.x · Cited by 46
Circadian influences on myocardial infarction
Virag, J. A. I., & Lust, R. M. (2014) · Frontiers in Physiology · doi:10.3389/fphys.2014.00422 · Cited by 47
Krieg, T., Liu, Y., Rutz, T., Methner, C., Yang, X. M., Dost, T., Felix, S. B., Stasch, J. P., Cohen, M. V., & Downey, J. M. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp143 · Cited by 45
Self-citationProtection of the ischaemic heart: investigations into the phenomenon of ischaemic preconditioning.
Lochner, A., Marais, E. M., Genade, S., Huisamen, B., Toit, E. F. D., & Moolman, J. (2009) · PubMed Central · Cited by 44
Nishida, H., Sato, T., Miyazaki, M., & NAKAYA, H. (2007) · Cardiovascular Research · doi:10.1016/j.cardiores.2007.07.015 · Cited by 44
Zhu, Q., Luo, Y., Wen, Y., Wang, D., Li, J., & Fan, Z. (2023) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2023.01.049 · Cited by 44
Nitric oxide and renal protection in morphine-dependent rats
Habibey, R., Ajami, M., Ebrahimi, S. A., Hesami, A., Babakoohi, S., & Pazoki–Toroudi, H. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.06.024 · Cited by 43
Kong, H., Li, Z., Zhao, Y., Zhao, S.-M., Zhu, L., Li, T., Fu, Y., & Li, H. (2010) · Acta Pharmacologica Sinica · doi:10.1038/aps.2010.52 · Cited by 43
Maimaitiyiming, H., Li, Y., Cui, W., Tong, X., Norman‐Burgdolf, H., Qi, X., & Wang, S. (2013) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00192.2013 · Cited by 43
A concise discussion of the regulatory role of cGMP kinase I in cardiac physiology and pathology
Hofmann, F. B. (2018) · Basic Research in Cardiology · doi:10.1007/s00395-018-0690-1 · Cited by 43
Madhani, M., Hall, A. R., Cuello, F., Charles, R. L., Burgoyne, J. R., Fuller, W., Hobbs, A. J., Shattock, M. J., & Eaton, P. (2010) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00129.2010 · Cited by 42
O'Rourke, B. P., Eyk, J. E. V., & Foster, D. B. (2011) · Congestive Heart Failure · doi:10.1111/j.1751-7133.2011.00266.x · Cited by 42
Downey, J. M., & Cohen, M. V. (2006) · Basic Research in Cardiology · doi:10.1007/s00395-006-0586-3 · Cited by 41
Self-citationPharmacological targets revealed by myocardial postconditioning
Burley, D. S., & Baxter, G. F. (2008) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2008.11.009 · Cited by 40
Juhaszova, M., Kobrinsky, E., Zorov, D. B., Nuss, H. B., Yaniv, Y., Fishbein, K. W., de Cabo, R., Montoliu, L., Gabelli, S. B., Aon, M. A., et al. (2022) · Function · doi:10.1093/function/zqac001 · Cited by 40
Nrf2-regulated antioxidant response is activated by protein kinase C in postconditioned rat hearts
Buelna‐Chontal, M., Guevara-Chávez, J.-G., Silva‐Palacios, A., Medina‐Campos, O. N., Pedraza‐Chaverrí, J., & Zazueta, C. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.06.021 · Cited by 39
MitoKATP activity in healthy and ischemic hearts
Costa, A. D. T., & Garlid, K. (2009) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-009-9213-y · Cited by 39
Self-citationProspects for Creation of Cardioprotective Drugs Based on Cannabinoid Receptor Agonists
Маслов, Л. Н., Khaliulin, I., Zhang, Y., Krylatov, A. V., Naryzhnaya, N. V., Mechoulam, R., PETROCELLIS, L. D., & Downey, J. M. (2015) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/1074248415612593 · Cited by 39
Self-citationJiang, M. T., Ljubković, M., Nakae, Y., Shi, Y., Kwok, W., Stowe, D. F., & Bosnjak, Z. J. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01084.2005 · Cited by 36
The mitochondrial permeability transition pore as a target of cardioprotective signaling
Baines, C. P. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00575.2007 · Cited by 35
Cardiac mitochondrial ATP‐sensitive potassium channel is activated by nitric oxide in vitro
Ljubković, M., Shi, Y., Cheng, Q., Bosnjak, Z. J., & Jiang, M. T. (2007) · FEBS Letters · doi:10.1016/j.febslet.2007.07.071 · Cited by 35
Badalzadeh, R., Yousefi, B., Majidinia, M., & Ebrahimi, H. (2014) · The Journal of Physiological Sciences · doi:10.1007/s12576-014-0333-8 · Cited by 35
Hamid, S. A., Totzeck, M., Drexhage, C., Thompson, I. R., Fowkes, R. C., Rassaf, T., & Baxter, G. F. (2009) · Basic Research in Cardiology · doi:10.1007/s00395-009-0058-7 · Cited by 36
New properties of mitochondrial ATP-regulated potassium channels
Bednarczyk, P., Dołowy, K., & Szewczyk, A. M. (2008) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-008-9153-y · Cited by 34
Khairallah, R. J., Khairallah, M., Gélinas, R., Bouchard, B., Young, M. E., Allen, B. G., Lopaschuk, G. D., Deschepper, C. F., & Rosiers, C. D. (2008) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2008.05.012 · Cited by 32
Kuno, A., Critz, S. D., Cohen, M. V., & Downey, J. M. (2006) · Basic Research in Cardiology · doi:10.1007/s00395-006-0612-5 · Cited by 31
Self-citationYu, Q., Nguyen, T. T. M., Ogbi, M., Caldwell, R. W., & Johnson, J. A. (2008) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.91476.2007 · Cited by 30
Pasdois, P., Beauvoit, B. P., Costa, A. D. T., Jaspard‐Vinassa, B., Tariosse, L., Bonoron‐Adèle, S., Garlid, K., & Santos, P. D. D. (2006) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2006.12.014 · Cited by 30
Self-citationFocus on: The cardiovascular system: what did we learn from the French (Paradox)?
Mochly‐Rosen, D., & Zakhari, S. (2010) · Europe PMC (PubMed Central) · Cited by 29
Chai, Y., & Lin, Y. (2008) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-008-0447-z · Cited by 29
Nishida, H., Sato, T., Ogura, T., & Nakaya, H. (2009) · Journal of Pharmacological Sciences · doi:10.1254/jphs.08r24fm · Cited by 29
Jiang, M. T., Nakae, Y., Ljubković, M., Kwok, W., Stowe, D. F., & Bosnjak, Z. J. (2007) · Anesthesia & Analgesia · doi:10.1213/01.ane.0000278640.81206.92 · Cited by 29
Vardenafil protects isolated rat hearts at reperfusion dependent on GC and PKG
Maas, O., Donat, U., Frenzel, M., Rütz, T., Kroemer, H. K., Felix, S. B., & Krieg, T. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.71 · Cited by 29
Badalzadeh, R., Yousefi, B., Tajaddini, A., & Ahmadian, N. (2014) · Perfusion · doi:10.1177/0267659114566064 · Cited by 27
Nakamura, T., & Tsujita, K. (2021) · Journal of Cardiology · doi:10.1016/j.jjcc.2021.03.004 · Cited by 29
Guo, Y., Li, Q., Wu, W., Tan, W. F., Zhu, X., Mu, J., & Bolli, R. (2008) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2008.01.003 · Cited by 28
Effects of soluble guanylate cyclase activation on heart transplantation in a rat model
Loganathan, S., Korkmaz‐Icöz, S., Radovits, T., Li, S., Mikles, B., Barnucz, E., Hirschberg, K., Karck, M., & Szabo, G. B. (2015) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2015.05.006 · Cited by 28
Shen, M., Hsiao, G., Fong, T., Chou, D., & Sheu, J. (2008) · Pharmacological Research · doi:10.1016/j.phrs.2008.01.004 · Cited by 28
Tessier‐Vetzel, D., Tissier, R., Waintraub, X., Ghaleh, B., & Berdeaux, A. (2006) · Journal of Cardiovascular Pharmacology · doi:10.1097/01.fjc.0000211731.69045.fe · Cited by 26
Signaling Mechanisms in Ischemic Preconditioning
Ardehali, H. (2006) · Circulation Research · doi:10.1161/01.res.0000247029.31997.a4 · Cited by 26
Martı́n-Puig, S., Tello, D., & Aragonés, J. (2015) · Frontiers in Physiology · doi:10.3389/fphys.2015.00137 · Cited by 26
Boulghobra, D., Dubois, M., Alpha‐Bazin, B., Coste, F., Olmos, M., Gayrard, S., Bornard, I., Meyer, G., Gaillard, J., Armengaud, J., et al. (2021) · Basic Research in Cardiology · doi:10.1007/s00395-021-00906-3 · Cited by 25
Wang, Y., Li, Y., Lin, L., Yang, D., Zhou, K., & Li, Y. (2018) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b18-00212 · Cited by 26
Yu, J. D., & Miyamoto, S. (2021) · Cells · doi:10.3390/cells10123330 · Cited by 25
Saxena, P., Shaw, O. M., Misso, N. L. A., Naran, A., Shehatha, J. S., Newman, M. A. J., d’Udekem, Y., Thompson, P. J., & Konstantinov, I. E. (2009) · Journal of Surgical Research · doi:10.1016/j.jss.2009.11.011 · Cited by 24
Yamanaka, R., Shindo, Y., Hotta, K., Suzuki, K. A. O., & Oka, K. (2013) · FEBS Letters · doi:10.1016/j.febslet.2013.06.049 · Cited by 23
Remote ischaemic pre‐conditioning for the prevention of acute kidney injury
Ho, P. W., Pang, W., & Szeto, C. (2015) · Nephrology · doi:10.1111/nep.12614 · Cited by 23
Chai, Y., & Lin, Y. (2010) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00196.2009 · Cited by 23
Goñi‐Allo, B., Puerta, E., Ramos, M., Lasheras, B., Jordán, J., & Aguirre, N. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.05042.x · Cited by 23
Cardioprotection by Regular Ethanol Consumption: Potential Mechanisms and Clinical Application
Miyamae, M., Kaneda, K., Domae, N., & Figueredo, V. M. (2010) · Current Drug Abuse Reviews · doi:10.2174/1874473711003010039 · Cited by 22
cGMP and mitochondrial K+ channels—Compartmentalized but closely connected in cardioprotection
Łukowski, R., Santos, M. C., Kuret, A., & Ruth, P. (2021) · British Journal of Pharmacology · doi:10.1111/bph.15536 · Cited by 22
Myocardial ischemic protection in natural mammalian hibernation
Yan, L., Kudej, R. K., Vatner, D. E., & Vatner, S. F. (2015) · Basic Research in Cardiology · doi:10.1007/s00395-015-0462-0 · Cited by 22
Myocardial ischemic conditioning: Physiological aspects and clinical applications in cardiac surgery
Bousselmi, R., Lebbi, A., & Ferjani, M. (2013) · Journal of the Saudi Heart Association · doi:10.1016/j.jsha.2013.11.001 · Cited by 22
Targets of cGMP/cGKI in Cardiac Myocytes
Adler, J., Kuret, A., Längst, N., & Łukowski, R. (2020) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000817 · Cited by 21
Sildenafil Citrate Augments Myocardial Protection in Heart Transplantation
Botha, P., MacGowan, G. A., & Dark, J. H. (2010) · Transplantation · doi:10.1097/tp.0b013e3181c42b22 · Cited by 21
The Role of cGMP-Dependent Protein Kinase in Controlling Cardiomyocyte cGMP
Francis, S. H. (2010) · Circulation Research · doi:10.1161/circresaha.110.233239 · Cited by 21
Маслов, Л. Н., Popov, S. V., Naryzhnaya, N. V., Mukhomedzyanov, А. V., Kurbatov, B. K., Андреевич, Д. И., Boshchenko, A. A., Prasad, N. R., Ma, H., Zhang, Y., et al. (2023) · Fundamental and Clinical Pharmacology · doi:10.1111/fcp.12924 · Cited by 21
Pathophysiologic role of ischemia reperfusion injury: A review
Vishwakarma, V. K., Upadhyay, P. K., Gupta, J. K., & Yadav, H. N. (2017) · Journal of Indian College of Cardiology · doi:10.1016/j.jicc.2017.06.017 · Cited by 20
Arandarčikaitė, O., Jokubka, R., & Borutaitė, V. (2014) · Neuroscience Letters · doi:10.1016/j.neulet.2014.09.012 · Cited by 19
Pamenter, M. E., Shin, D. S., & Buck, L. T. (2008) · Brain Research · doi:10.1016/j.brainres.2008.03.047 · Cited by 20
da Silva, I. B., Gomes, D. A., Alenina, N. V., Bäder, M., Santos, R. A. S., & Barreto‐Chaves, M. L. M. (2017) · Heart and Vessels · doi:10.1007/s00380-017-1101-5 · Cited by 18
Pathological Responses of Cardiac Mitochondria to Burn Trauma
Wang, M., Scott, S. R., Koniaris, L. G., & Zimmers, T. A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186655 · Cited by 17
Lee, W.-Y., Koh, E., & Lee, S. (2011) · Nitric Oxide · doi:10.1016/j.niox.2011.11.002 · Cited by 17
Molecular Mechanisms of Ischemic Conditioning: Translation Into Patient Outcomes
Brooks, M. J., & Andrews, D. T. (2013) · Future Cardiology · doi:10.2217/fca.13.30 · Cited by 17
Chen, Z., Spahn, D. R., Zhang, X., Liu, Y., Chu, H., & Liu, Z. (2016) · Cellular Physiology and Biochemistry · doi:10.1159/000447890 · Cited by 17
Costa, A. D. T., & Krieger, M. A. (2009) · International Journal for Parasitology · doi:10.1016/j.ijpara.2009.01.002 · Cited by 17
Self-citation
Metadata
- Authors
- Costa, A. D. T., Garlid, K. D., West, I. C., Lincoln, T. M., Downey, J. M., Cohen, M. V., & Critz, S. D.
- Affiliations
- Portland State University (US)
- Venue
- Circulation Research
- Published
- 2005-08-19
- Volume
- 97
- Issue
- 4
- Pages
- 329-336
- ISSN
- 0009-7330 (ISSN-L)
- 1524-4571
- OpenAlex
- W2151589110
- Cited by
- 307
- References
- 44
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 1 · 2023: 5 · 2022: 4 · 2021: 6 · 2020: 8 · 2019: 8 · 2018: 8 · 2017: 7 · 2016: 7 · 2015: 15 · 2014: 15 · 2013: 20 · 2012: 14
- FWCI
- 22.20
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Circulation Research (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Heart, Lung, and Blood Institute (HL20648, HL35673, HL-67842, R01HL050688, HL50688, R01HL020648, R01HL067842)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Ischemia and Reperfusion
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
- Keywords
- protein kinase G, mitochondrial KATP channels, cardioprotection, preconditioning, cyclic GMP, protein kinase C epsilon, ischemia, reactive oxygen species, mitochondrial respiration, potassium transport, endothelial nitric oxide synthase, guanylate cyclase, phosphatidylinositol 3-kinase, signal transduction
- MeSH terms
- Adenosine Triphosphate, Animals, Brain, Cytosol, Cyclic GMP, Male, Mitochondria, Heart, Mitochondria, Liver, Oxygen Consumption, Protein Kinase C, Tetradecanoylphorbol Acetate, Tetraethylammonium Compounds, Potassium Channels, Signal Transduction, Rats, Wistar, Cyclic GMP-Dependent Protein Kinases, Ischemic Preconditioning, Myocardial, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review